Now Accepting New Patients — Schedule a consultation with Dr. Voight
Book Consultation
Physician-supervised peptide protocols

Discover if peptide therapy is the right approach for your health goals

Dr. Frederich Voight provides personalized, evidence-based peptide protocols — including tirzepatide and retatrutide — with comprehensive medical oversight at every step.

Schedule a Consultation
Board-certified physician
Evidence-based protocols
Ongoing lab monitoring
Individual results vary. All treatments require a medical evaluation. Peptide therapy may not be appropriate for everyone. A consultation with Dr. Voight will determine if you are a candidate.
Understanding Peptide Therapy

What are GLP-1 and GIP receptor agonists?

Peptide-based therapies represent an evolving area of metabolic medicine. These compounds work by mimicking natural hormones involved in appetite regulation, blood sugar management, and metabolic function.

Researchers have been studying molecules that target GLP-1, GIP, and glucagon receptors — and clinical trials have shown promising results in supporting metabolic health when used under proper medical supervision.

Dr. Voight stays current with the latest published research and clinical guidelines to offer his patients access to appropriate peptide protocols, always with thorough medical evaluation first.

Why medical supervision matters: Peptide therapies require proper dosing, gradual titration, and regular lab monitoring. Working with a qualified physician helps ensure safety and allows your protocol to be adjusted based on how your body responds.
Treatment Options

Peptides Dr. Voight may recommend

During your consultation, Dr. Voight will review your health history, lab work, and goals to determine which approach — if any — may be appropriate for you.

Dual-Receptor GIP/GLP-1

Tirzepatide

FDA-approved · Weekly subcutaneous injection

Tirzepatide is an FDA-approved medication that activates both GIP and GLP-1 receptors. It was originally developed for type 2 diabetes management and has also received approval for chronic weight management in eligible patients.

  • FDA-approved for chronic weight management and type 2 diabetes
  • Studied in large-scale clinical trials (SURMOUNT, SURPASS)
  • Supports appetite regulation and metabolic health markers
  • Once-weekly dosing with physician-guided titration

Eligibility is determined during your medical evaluation. Not appropriate for all patients.

Triple-Receptor GIP/GLP-1/Glucagon

Retatrutide

Investigational · Currently in clinical trials

Retatrutide is an investigational triple-receptor agonist currently being studied in Phase 3 clinical trials. It targets GIP, GLP-1, and glucagon receptors — a novel approach that researchers are evaluating for metabolic health applications.

  • Novel triple-receptor mechanism under active clinical investigation
  • Phase 2 results published in peer-reviewed journals
  • Being studied for metabolic and liver health outcomes
  • Availability subject to regulatory status and physician evaluation

Retatrutide is not yet FDA-approved. Dr. Voight can discuss current research and whether you may be a candidate for available options during your consultation.

Your Journey

How it works

A structured, physician-led process from evaluation to ongoing care.

01

Medical Evaluation

Meet with Dr. Voight for a thorough review of your health history, current medications, and goals. Comprehensive lab work is ordered to assess your metabolic baseline.

02

Personalized Plan

Based on your evaluation and lab results, Dr. Voight determines if peptide therapy is appropriate and designs a customized protocol with clear dosing guidelines and nutritional recommendations.

03

Ongoing Monitoring

Regular follow-up appointments, lab panels, and dose adjustments ensure your protocol remains safe and aligned with your progress. Direct access to Dr. Voight's clinical team.

Your Physician

Dr. Frederich Voight, M.D.

Board-Certified · Metabolic & Peptide Medicine

Dr. Voight brings over 15 years of clinical experience to his practice, with a focus on metabolic health and evidence-based peptide therapies. He believes in a thorough, patient-centered approach where every treatment decision is grounded in lab data and ongoing evaluation.

His practice emphasizes transparency: he discusses both the potential benefits and the limitations of any therapy, so patients can make informed decisions about their care.

  • Board Certified
  • Metabolic Medicine
  • Peptide Therapy
  • 15+ Years Practice
Patient Experiences

What patients say about working with Dr. Voight

These testimonials reflect individual experiences. Results vary from person to person.

★★★★★

"Dr. Voight took the time to review my full medical history before recommending anything. I felt like he genuinely cared about finding the right approach for my situation, not just prescribing a one-size-fits-all solution."

Sarah M.
Patient since 2024
★★★★★

"The regular bloodwork and check-ins gave me confidence that everything was being monitored properly. Dr. Voight adjusted my protocol based on my lab results, and I always felt informed about what was happening."

Michael T.
Patient since 2023
★★★★★

"What I appreciate most is Dr. Voight's honesty. He told me upfront what peptide therapy could and couldn't do, set realistic expectations, and his team was always available when I had questions."

Jennifer L.
Patient since 2024

Individual experiences are not guarantees of specific outcomes. A medical evaluation is required to determine if peptide therapy is appropriate for you.

Common Questions

Frequently asked questions

Candidacy depends on your individual health profile, medical history, current medications, and goals. Not everyone is a candidate for peptide therapy. During your consultation, Dr. Voight will review your complete health picture and lab work to determine if this approach is appropriate and safe for you.
Tirzepatide is FDA-approved and targets two receptors (GIP and GLP-1). Retatrutide is investigational and targets three receptors (adding glucagon). They have different mechanisms and regulatory statuses. Dr. Voight will explain the current evidence for each and help you understand which options are available based on your health needs.
Your first visit includes a comprehensive health history review, discussion of your goals, and ordering of metabolic lab panels. Dr. Voight will explain available treatment options, potential benefits, possible side effects, and help you decide on next steps. There is no obligation to proceed with treatment after your consultation.
Like all medications, peptide therapies can have side effects. The most commonly reported include mild gastrointestinal symptoms such as nausea, which often improve with gradual dose titration. Dr. Voight discusses all potential risks during your evaluation and monitors for side effects throughout your treatment with regular lab work and follow-ups.
Yes. Dr. Voight offers telehealth consultations for eligible patients. During scheduling, his team will confirm whether a virtual or in-person visit is appropriate based on your state of residence and medical needs.
Get Started

Find out if peptide therapy is right for you

Schedule a consultation with Dr. Voight to discuss your health goals and explore your options with a board-certified physician.

Schedule Your Consultation

No obligation · Confidential · Telehealth available

Schedule Your Consultation →